Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Zacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak Energy

Zacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak Energy

HIVE : 5.48 (+0.55%)
RWLK : 1.08 (-2.27%)
CLD : 4.18 (-1.18%)
CERS : 3.64 (-0.27%)
DS : 5.83 (-1.19%)
5 Breakout Stocks Offering Admirable Returns

Nearly as favored a strategy as it is divisive, picking breakout stocks is one of the most used techniques for active investors.

HIVE : 5.48 (+0.55%)
RWLK : 1.08 (-2.27%)
CLD : 4.18 (-1.18%)
CERS : 3.64 (-0.27%)
DS : 5.83 (-1.19%)
Cerus Corporation Receives IDE Approval to Initiate Phase III ReCePI Study

Cerus Corporation (NASDAQ: CERS) today announced it has received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate ReCePI (A...

CERS : 3.64 (-0.27%)
Technical Insights on Biotech Stocks -- Cara Therapeutics, Catabasis Pharma, Cerus, and Genocea Biosciences

If you want a Stock Review on CARA, CATB, CERS, or GNCA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Friday, benchmark US indices were in bullish...

CARA : 13.54 (+3.60%)
CATB : 1.79 (+1.70%)
GNCA : 1.10 (unch)
CERS : 3.64 (-0.27%)
Cerus Corporation Reports Third Quarter 2017 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the third quarter ended September 30, 2017.

CERS : 3.64 (-0.27%)
Cerus to Present at Two Upcoming Conferences

Cerus Corporation (NASDAQ:CERS) announced today that management will present at two upcoming investor conferences:

CERS : 3.64 (-0.27%)
Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy

Cerus Corporation (NASDAQ:CERS) announced today that it has entered into an agreement with Kedrion Biopharma to distribute the full complement of INTERCEPT Blood System products in Italy....

CERS : 3.64 (-0.27%)
Cerus Announces Agreement with Transfusion Center of the Community of Madrid

Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a supply agreement with Centro de Transfusion de la Comunidad de Madrid (CTCM) for the INTERCEPT Blood System for...

CERS : 3.64 (-0.27%)
Cerus Announces National German Reimbursement for Pathogen Inactivated Platelets

Cerus Corporation (NASDAQ:CERS) announced today that the Institute for the Hospital Remuneration System (Institut fur das Entgeltsystem im Krankenhaus, or InEK) in Germany will include pathogen-inactivated...

CERS : 3.64 (-0.27%)
Cerus to Release Third Quarter 2017 Results on November 2, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its third quarter results will be released on Thursday, November 2, 2017, after the close of the stock market. The company will host a...

CERS : 3.64 (-0.27%)
Cerus Corporation (CERS) Looks Good: Stock Adds 8.2% in Session

Cerus Corporation (CERS) saw its shares rise over 8% on the day on the back of the news of a favorable regulatory development.

ESLOY : 67.3200 (-0.34%)
CERS : 3.64 (-0.27%)
Cerus Announces First Biologics License Application Approval for U.S. Blood Center Customer

Cerus Corporation (NASDAQ:CERS) announced today that Rhode Island Blood Center received approval by the U.S. Food and Drug Administration (FDA) on their Biologics License Application (BLA)...

CERS : 3.64 (-0.27%)
Cerus Announces Schedule of Presentations at the 2017 AABB Annual Meeting

Cerus Corporation (NASDAQ:CERS) announced today its schedule of key events at the AABB (formerly known as the American Association of Blood Banks) Annual Meeting to be held October 7-10 in...

CERS : 3.64 (-0.27%)
Cerus to Present at Cantor Fitzgerald's Annual Healthcare Conference on September 27, 2017

Cerus Corporation (NASDAQ:CERS) announced today that William 'Obi' Greenman, Cerus' president and chief executive officer, is scheduled to present a corporate update at the Cantor Fitzgerald...

CERS : 3.64 (-0.27%)
Cerus to Present at Two Upcoming Conferences

Cerus Corporation (NASDAQ:CERS) announced today that William 'Obi' Greenman, Cerus' president and chief executive officer, will present at two upcoming conferences:

CERS : 3.64 (-0.27%)
Today's Research Report Coverage on Biotech Stocks -- Bellicum Pharma, Cara Therapeutics, Cerus, and Coherus Biosciences

If you want a Stock Review on BLCM, CARA, CERS, or CHRS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. This morning, DailyStockTracker.com revisits...

CARA : 13.54 (+3.60%)
CHRS : 9.05 (+7.10%)
BLCM : 9.53 (+3.47%)
CERS : 3.64 (-0.27%)
Cerus Enters Into $40 Million Amended Growth Capital Agreement

Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a $40 million amended growth capital credit facility with Oxford Finance LLC, a specialty finance firm that provides...

CERS : 3.64 (-0.27%)
Cerus Announces Collaboration with Central California Blood Center to Manufacture Pathogen-Reduced Cryoprecipitate

Cerus Corporation (NASDAQ:CERS) announced today an agreement with the Central California Blood Center (CCBC) in which CCBC will manufacture pathogen-reduced cryoprecipitate ("cryo") for the...

CERS : 3.64 (-0.27%)
Cerus to Release Second Quarter 2017 Results on August 3, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, August 3, 2017, after the close of the stock market. The company will host a...

CERS : 3.64 (-0.27%)
INTERCEPT Blood System Highlighted at the International Society of Blood Transfusion (ISBT)

Cerus Corporation (NASDAQ:CERS) announced results of 16 abstracts presenting experiences with the INTERCEPT Blood System for platelets, plasma, and red blood cells during the 27th Regional...

CERS : 3.64 (-0.27%)

Van Meerten Stock Picks

5 Great Large Caps
Today I wanted to find 5 Large Caps that still had some upside potential.
ALL +0.39 , AMP +2.26 , LB +2.18 , AXP -0.03 , AKAM +0.06
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.09%) this morning are up +0.08% and European stocks are down -0.12% . Most global stocks markets moved higher ahead of central bank meetings this week from the Fed, ECB and BOE. U.S.... Read More

Chart of the Day

Chart of the Day

Viking Therapeutics (VKTX) is the Barchart Chart of the Day.  The biopharmaceutical company has a Trend Spotter, a Weighted Alpha of 206.52+ and gained 254.95% in the last year
Read More

Brugler Ag Report

Today's Commentary

Corn futures saw gains of 1/4 to 1 1/4 cents on Friday, as Dec gave back last week’s gains, down 1.38% for the week. The weekly Commitment of Traders report showed spec traders continuing to reduce their net short position by another 36,244 con...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.